##  [FDA Advisory Committee supports use of tobramycin inhalation powder from Novartis for patients with cystic fibrosis](/us-en/news/media-releases/fda-advisory-committee-supports-use-tobramycin-inhalation-powder-from-novartis-patients-cystic-fibrosis-0 "FDA Advisory Committee supports use of tobramycin inhalation powder from Novartis for patients with cystic fibrosis") 

  Sep 05, 2012